Morphic

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

1 month ago   |   Xconomy

Scan the landscape of experimental medicines in development today and you'll spot Schrödinger's handiwork. The company's software has helped discover compounds that are now...
Read more ...

The Finalists for the 2019 Xconomy Awards Are

The Finalists for the 2019 Xconomy Awards Are

7 monthes ago   |   Xconomy

After a robust discussion, the editors and judges have narrowed down an impressive list of nearly 300 nominees for the 2019 Xconomy Awards in Boston to an all-star group of...
Read more ...

Development of Ionic Liquid‐Water‐Based Thermomorphic Solvent ‐Systems for Biocatalytic Reactions

8 monthes ago   |   Wiley

Abstract The applicability of ionic liquid‐water‐based thermo‐morphic solvent ‐systems with an upper critical solution temperature for homogeneous biocatalysis was...
Read more ...

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

One year ago   |   Xconomy

The growing epidemic of the fatty liver disease known as NASH, which has no FDA-approved treatment, has led to a frenzied race among drug companies. This week, one company...
Read more ...

Morphic bags J&J as second big pharma partner for oral integrins

One year ago   |   Fierce Biotech

Johnson & Johnson has joined AbbVie as a partner for Morphic Therapeutic and its small-molecule integrin platform, pledging up to $725 million to the cause.
Read more ...

Gilead, Scholar Rock Sign $80M Up Front Deal for Fibrosis Drugs

Gilead, Scholar Rock Sign $80M Up Front Deal for Fibrosis Drugs

One year ago   |   Xconomy

Drugmakers are increasingly turning their attention toward fibrosis, the excessive growth of connective tissue that can lead to scarring and dysfunction of multiple organs...
Read more ...

Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive's End

One year ago   |   Xconomy

Two new battlegrounds emerged this week in the nation's ongoing drug pricing debate. The first involved television: The federal government hopes that blaring prices in TV ads...
Read more ...

AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance

AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance

One year ago   |   Xconomy

AbbVie is positioning itself to add fibrosis drugs to its pipeline through a new research and development partnership with startup Morphic Therapeutics. Under the agreement...
Read more ...

Bio Roundup: Amarin's Stunner, Lung Cancer News, Data Dumps & More

Bio Roundup: Amarin's Stunner, Lung Cancer News, Data Dumps & More

One year ago   |   Xconomy

Six years ago, a biotech called Amarin won FDA approval of a prescription fish-oil pill, Vascepa, because it could lower triglycerides, a type of fat in the blood. But Amarin...
Read more ...

Morphic raises $80M to test its oral integrin-based drugs

One year ago   |   Fierce Biotech   |   2 articles

Morphic Therapeutic brought in $80 million to carry its two lead integrin-targeting programs through their clinical proof-of-concept studies, as well as to help move several...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

IAmScience George Stewart

IAmScience George Stewart

By Becca Wolf | Bond LSC Medical bacteriologist, George Stewart has had a few stops along the way before he got to Bond LSC in 2004. Having done schooling and research at... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...